Coherus Biosciences | Capital De Empréstimo

Preço das Ações
2.15
Mudança Diária
0.09 4.13%
Mensal
30.00%
Anual
93.24%
Q1 Previsão
2.39




Capital De Empréstimo Alterar Data
AbbVie USD 62.97B 12M 2025-09
Acadia Pharmaceuticals USD 0 0 2025-03
Akebia Therapeutics USD 47.64M 579K 2025-09
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Amgen USD 50B 2.43B 2025-12
Baxter International USD 9.49B 80M 2025-06
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 294.85M 2.33M 2025-03
Eli Lilly USD 40.87B 6.69B 2025-09
Fujifilm JPY 642.24B 70.37B 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 39.97B 6B 2025-09
Myriad Genetics USD 119.5M 60.2M 2025-09
Pacira USD 376.72M 1.37M 2025-09
Perrigo USD 3.61B 7.4M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xencor USD 87.78M 6.96M 2025-09
Zoetis USD 7.07B 1.84B 2025-09


Coherus Biosciences Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.